CN101968440B - 一种利用表面等离子谐振技术检测特定糖链蛋白、抗体或抗原的生物芯片 - Google Patents
一种利用表面等离子谐振技术检测特定糖链蛋白、抗体或抗原的生物芯片 Download PDFInfo
- Publication number
- CN101968440B CN101968440B CN2009103048853A CN200910304885A CN101968440B CN 101968440 B CN101968440 B CN 101968440B CN 2009103048853 A CN2009103048853 A CN 2009103048853A CN 200910304885 A CN200910304885 A CN 200910304885A CN 101968440 B CN101968440 B CN 101968440B
- Authority
- CN
- China
- Prior art keywords
- antibody
- antigen
- sugar chain
- biochip
- specific sugar
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 239000000427 antigen Substances 0.000 title claims abstract description 41
- 108091007433 antigens Proteins 0.000 title claims abstract description 41
- 102000036639 antigens Human genes 0.000 title claims abstract description 41
- 238000005516 engineering process Methods 0.000 title claims abstract description 19
- 102000003886 Glycoproteins Human genes 0.000 title abstract description 23
- 108090000288 Glycoproteins Proteins 0.000 title abstract description 23
- 238000002198 surface plasmon resonance spectroscopy Methods 0.000 title abstract description 4
- 238000001514 detection method Methods 0.000 claims abstract description 27
- 238000000034 method Methods 0.000 claims abstract description 27
- 101710186708 Agglutinin Proteins 0.000 claims abstract description 23
- 101710146024 Horcolin Proteins 0.000 claims abstract description 23
- 101710189395 Lectin Proteins 0.000 claims abstract description 23
- 101710179758 Mannose-specific lectin Proteins 0.000 claims abstract description 23
- 101710150763 Mannose-specific lectin 1 Proteins 0.000 claims abstract description 23
- 101710150745 Mannose-specific lectin 2 Proteins 0.000 claims abstract description 23
- 239000000910 agglutinin Substances 0.000 claims abstract description 23
- 229910052751 metal Inorganic materials 0.000 claims abstract description 22
- 239000002184 metal Substances 0.000 claims abstract description 22
- 108090000623 proteins and genes Proteins 0.000 claims abstract description 18
- 102000004169 proteins and genes Human genes 0.000 claims abstract description 16
- 239000000758 substrate Substances 0.000 claims abstract description 5
- 238000006243 chemical reaction Methods 0.000 claims description 25
- 238000000018 DNA microarray Methods 0.000 claims description 24
- 150000004676 glycans Chemical class 0.000 claims description 16
- 239000013545 self-assembled monolayer Substances 0.000 claims description 16
- 238000012360 testing method Methods 0.000 claims description 15
- 239000002094 self assembled monolayer Substances 0.000 claims description 14
- UCKMPCXJQFINFW-UHFFFAOYSA-N Sulphide Chemical compound [S-2] UCKMPCXJQFINFW-UHFFFAOYSA-N 0.000 claims description 12
- 229920001282 polysaccharide Polymers 0.000 claims description 12
- 239000005017 polysaccharide Substances 0.000 claims description 12
- LMDZBCPBFSXMTL-UHFFFAOYSA-N 1-ethyl-3-(3-dimethylaminopropyl)carbodiimide Chemical class CCN=C=NCCCN(C)C LMDZBCPBFSXMTL-UHFFFAOYSA-N 0.000 claims description 11
- 230000002159 abnormal effect Effects 0.000 claims description 10
- 229920001503 Glucan Polymers 0.000 claims description 7
- TWNIBLMWSKIRAT-VFUOTHLCSA-N levoglucosan Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@H]2CO[C@@H]1O2 TWNIBLMWSKIRAT-VFUOTHLCSA-N 0.000 claims description 7
- 229920000620 organic polymer Polymers 0.000 claims description 6
- BRLQWZUYTZBJKN-UHFFFAOYSA-N Epichlorohydrin Chemical compound ClCC1CO1 BRLQWZUYTZBJKN-UHFFFAOYSA-N 0.000 claims description 5
- 230000004913 activation Effects 0.000 claims description 5
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 claims description 5
- WBJINCZRORDGAQ-UHFFFAOYSA-N ethyl formate Chemical compound CCOC=O WBJINCZRORDGAQ-UHFFFAOYSA-N 0.000 claims description 5
- 230000008569 process Effects 0.000 claims description 5
- 238000005259 measurement Methods 0.000 claims description 4
- BASFCYQUMIYNBI-UHFFFAOYSA-N platinum Chemical compound [Pt] BASFCYQUMIYNBI-UHFFFAOYSA-N 0.000 claims description 4
- 238000012545 processing Methods 0.000 claims description 4
- GIAFURWZWWWBQT-UHFFFAOYSA-N 2-(2-aminoethoxy)ethanol Chemical compound NCCOCCO GIAFURWZWWWBQT-UHFFFAOYSA-N 0.000 claims description 3
- 230000015572 biosynthetic process Effects 0.000 claims description 3
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims description 3
- 150000002924 oxiranes Chemical class 0.000 claims description 3
- OMDQUFIYNPYJFM-XKDAHURESA-N (2r,3r,4s,5r,6s)-2-(hydroxymethyl)-6-[[(2r,3s,4r,5s,6r)-4,5,6-trihydroxy-3-[(2s,3s,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]methoxy]oxane-3,4,5-triol Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@@H]1OC[C@@H]1[C@@H](O[C@H]2[C@H]([C@@H](O)[C@H](O)[C@@H](CO)O2)O)[C@H](O)[C@H](O)[C@H](O)O1 OMDQUFIYNPYJFM-XKDAHURESA-N 0.000 claims description 2
- 229920000936 Agarose Polymers 0.000 claims description 2
- 229920000926 Galactomannan Polymers 0.000 claims description 2
- 229920000057 Mannan Polymers 0.000 claims description 2
- 125000000217 alkyl group Chemical group 0.000 claims description 2
- 238000004132 cross linking Methods 0.000 claims description 2
- 229930182830 galactose Natural products 0.000 claims description 2
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims description 2
- HOGDNTQCSIKEEV-UHFFFAOYSA-N n'-hydroxybutanediamide Chemical compound NC(=O)CCC(=O)NO HOGDNTQCSIKEEV-UHFFFAOYSA-N 0.000 claims description 2
- 229920001277 pectin Polymers 0.000 claims description 2
- 239000001814 pectin Substances 0.000 claims description 2
- 235000010987 pectin Nutrition 0.000 claims description 2
- 229910052697 platinum Inorganic materials 0.000 claims description 2
- 150000004804 polysaccharides Polymers 0.000 claims description 2
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 claims description 2
- 239000000126 substance Substances 0.000 claims description 2
- 238000003786 synthesis reaction Methods 0.000 claims description 2
- 201000010099 disease Diseases 0.000 abstract description 9
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract description 9
- 230000003213 activating effect Effects 0.000 abstract description 6
- DNJIEGIFACGWOD-UHFFFAOYSA-N ethyl mercaptane Natural products CCS DNJIEGIFACGWOD-UHFFFAOYSA-N 0.000 abstract description 6
- DGVVWUTYPXICAM-UHFFFAOYSA-N β‐Mercaptoethanol Chemical compound OCCS DGVVWUTYPXICAM-UHFFFAOYSA-N 0.000 abstract description 6
- 238000003745 diagnosis Methods 0.000 abstract description 2
- 230000027455 binding Effects 0.000 abstract 1
- 230000009870 specific binding Effects 0.000 abstract 1
- 125000003396 thiol group Chemical class [H]S* 0.000 abstract 1
- 102000013529 alpha-Fetoproteins Human genes 0.000 description 24
- 108010026331 alpha-Fetoproteins Proteins 0.000 description 24
- 239000000243 solution Substances 0.000 description 22
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 10
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 10
- 239000007864 aqueous solution Substances 0.000 description 9
- 210000004027 cell Anatomy 0.000 description 9
- 210000002966 serum Anatomy 0.000 description 8
- 239000007853 buffer solution Substances 0.000 description 7
- 150000001720 carbohydrates Chemical class 0.000 description 7
- 239000003153 chemical reaction reagent Substances 0.000 description 7
- 238000013016 damping Methods 0.000 description 7
- 239000012530 fluid Substances 0.000 description 7
- HZAXFHJVJLSVMW-UHFFFAOYSA-N 2-Aminoethan-1-ol Chemical compound NCCO HZAXFHJVJLSVMW-UHFFFAOYSA-N 0.000 description 6
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 6
- 235000014633 carbohydrates Nutrition 0.000 description 6
- 238000011160 research Methods 0.000 description 6
- 206010028980 Neoplasm Diseases 0.000 description 5
- 108091034117 Oligonucleotide Proteins 0.000 description 5
- 238000004140 cleaning Methods 0.000 description 5
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 5
- 229910052737 gold Inorganic materials 0.000 description 5
- 239000010931 gold Substances 0.000 description 5
- 229910052757 nitrogen Inorganic materials 0.000 description 5
- 239000001509 sodium citrate Substances 0.000 description 5
- HRXKRNGNAMMEHJ-UHFFFAOYSA-K trisodium citrate Chemical compound [Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O HRXKRNGNAMMEHJ-UHFFFAOYSA-K 0.000 description 5
- 229940038773 trisodium citrate Drugs 0.000 description 5
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 4
- 239000012670 alkaline solution Substances 0.000 description 4
- 239000012153 distilled water Substances 0.000 description 4
- 239000010410 layer Substances 0.000 description 4
- 239000007974 sodium acetate buffer Substances 0.000 description 4
- 210000001519 tissue Anatomy 0.000 description 4
- -1 aminopropyl Chemical group 0.000 description 3
- 201000011510 cancer Diseases 0.000 description 3
- 230000008859 change Effects 0.000 description 3
- 230000002779 inactivation Effects 0.000 description 3
- 230000004054 inflammatory process Effects 0.000 description 3
- 201000007270 liver cancer Diseases 0.000 description 3
- 208000014018 liver neoplasm Diseases 0.000 description 3
- 230000004048 modification Effects 0.000 description 3
- 238000012986 modification Methods 0.000 description 3
- 108020004707 nucleic acids Proteins 0.000 description 3
- 102000039446 nucleic acids Human genes 0.000 description 3
- 150000007523 nucleic acids Chemical class 0.000 description 3
- 230000009467 reduction Effects 0.000 description 3
- 125000005629 sialic acid group Chemical group 0.000 description 3
- LFQCEHFDDXELDD-UHFFFAOYSA-N tetramethyl orthosilicate Chemical compound CO[Si](OC)(OC)OC LFQCEHFDDXELDD-UHFFFAOYSA-N 0.000 description 3
- GFLJTEHFZZNCTR-UHFFFAOYSA-N 3-prop-2-enoyloxypropyl prop-2-enoate Chemical compound C=CC(=O)OCCCOC(=O)C=C GFLJTEHFZZNCTR-UHFFFAOYSA-N 0.000 description 2
- 108010041397 CD4 Antigens Proteins 0.000 description 2
- 241000252506 Characiformes Species 0.000 description 2
- 240000008853 Datura stramonium Species 0.000 description 2
- AVXURJPOCDRRFD-UHFFFAOYSA-N Hydroxylamine Chemical compound ON AVXURJPOCDRRFD-UHFFFAOYSA-N 0.000 description 2
- 206010061218 Inflammation Diseases 0.000 description 2
- 241001465754 Metazoa Species 0.000 description 2
- 235000000208 Solanum incanum Nutrition 0.000 description 2
- 244000061458 Solanum melongena Species 0.000 description 2
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 2
- 240000002895 Vicia hirsuta Species 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- SQVRNKJHWKZAKO-UHFFFAOYSA-N beta-N-Acetyl-D-neuraminic acid Natural products CC(=O)NC1C(O)CC(O)(C(O)=O)OC1C(O)C(O)CO SQVRNKJHWKZAKO-UHFFFAOYSA-N 0.000 description 2
- 230000008827 biological function Effects 0.000 description 2
- 230000017531 blood circulation Effects 0.000 description 2
- 238000001816 cooling Methods 0.000 description 2
- 230000004069 differentiation Effects 0.000 description 2
- 208000016097 disease of metabolism Diseases 0.000 description 2
- 230000006870 function Effects 0.000 description 2
- 239000011521 glass Substances 0.000 description 2
- 239000005556 hormone Substances 0.000 description 2
- 229940088597 hormone Drugs 0.000 description 2
- 229910052739 hydrogen Inorganic materials 0.000 description 2
- 230000036039 immunity Effects 0.000 description 2
- 208000015181 infectious disease Diseases 0.000 description 2
- 230000003993 interaction Effects 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 210000004185 liver Anatomy 0.000 description 2
- 208000030159 metabolic disease Diseases 0.000 description 2
- 201000008383 nephritis Diseases 0.000 description 2
- 150000002482 oligosaccharides Polymers 0.000 description 2
- 230000007170 pathology Effects 0.000 description 2
- 238000005554 pickling Methods 0.000 description 2
- 229920000371 poly(diallyldimethylammonium chloride) polymer Polymers 0.000 description 2
- 238000002360 preparation method Methods 0.000 description 2
- 230000004044 response Effects 0.000 description 2
- 238000000682 scanning probe acoustic microscopy Methods 0.000 description 2
- 230000008054 signal transmission Effects 0.000 description 2
- 238000002791 soaking Methods 0.000 description 2
- 238000003756 stirring Methods 0.000 description 2
- 239000001117 sulphuric acid Substances 0.000 description 2
- 235000011149 sulphuric acid Nutrition 0.000 description 2
- 238000005406 washing Methods 0.000 description 2
- 241000251468 Actinopterygii Species 0.000 description 1
- 108010053481 Antifreeze Proteins Proteins 0.000 description 1
- 208000023275 Autoimmune disease Diseases 0.000 description 1
- 102000015081 Blood Coagulation Factors Human genes 0.000 description 1
- 108010039209 Blood Coagulation Factors Proteins 0.000 description 1
- 206010006187 Breast cancer Diseases 0.000 description 1
- 208000026310 Breast neoplasm Diseases 0.000 description 1
- 208000017897 Carcinoma of esophagus Diseases 0.000 description 1
- 102000014914 Carrier Proteins Human genes 0.000 description 1
- 108010078791 Carrier Proteins Proteins 0.000 description 1
- SHZGCJCMOBCMKK-UHFFFAOYSA-N D-mannomethylose Natural products CC1OC(O)C(O)C(O)C1O SHZGCJCMOBCMKK-UHFFFAOYSA-N 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 208000000461 Esophageal Neoplasms Diseases 0.000 description 1
- 229920002306 Glycocalyx Polymers 0.000 description 1
- 229920002527 Glycogen Polymers 0.000 description 1
- 208000005016 Intestinal Neoplasms Diseases 0.000 description 1
- SHZGCJCMOBCMKK-PQMKYFCFSA-N L-Fucose Natural products C[C@H]1O[C@H](O)[C@@H](O)[C@@H](O)[C@@H]1O SHZGCJCMOBCMKK-PQMKYFCFSA-N 0.000 description 1
- SHZGCJCMOBCMKK-DHVFOXMCSA-N L-fucopyranose Chemical compound C[C@@H]1OC(O)[C@@H](O)[C@H](O)[C@@H]1O SHZGCJCMOBCMKK-DHVFOXMCSA-N 0.000 description 1
- PNNNRSAQSRJVSB-UHFFFAOYSA-N L-rhamnose Natural products CC(O)C(O)C(O)C(O)C=O PNNNRSAQSRJVSB-UHFFFAOYSA-N 0.000 description 1
- 206010058467 Lung neoplasm malignant Diseases 0.000 description 1
- 206010027476 Metastases Diseases 0.000 description 1
- SQVRNKJHWKZAKO-PFQGKNLYSA-N N-acetyl-beta-neuraminic acid Chemical compound CC(=O)N[C@@H]1[C@@H](O)C[C@@](O)(C(O)=O)O[C@H]1[C@H](O)[C@H](O)CO SQVRNKJHWKZAKO-PFQGKNLYSA-N 0.000 description 1
- 208000002454 Nasopharyngeal Carcinoma Diseases 0.000 description 1
- 206010061306 Nasopharyngeal cancer Diseases 0.000 description 1
- 240000002853 Nelumbo nucifera Species 0.000 description 1
- 235000006508 Nelumbo nucifera Nutrition 0.000 description 1
- 241001597008 Nomeidae Species 0.000 description 1
- 206010061902 Pancreatic neoplasm Diseases 0.000 description 1
- 208000037273 Pathologic Processes Diseases 0.000 description 1
- 240000004713 Pisum sativum Species 0.000 description 1
- 235000010582 Pisum sativum Nutrition 0.000 description 1
- 206010060862 Prostate cancer Diseases 0.000 description 1
- 208000000236 Prostatic Neoplasms Diseases 0.000 description 1
- 102000006382 Ribonucleases Human genes 0.000 description 1
- 108010083644 Ribonucleases Proteins 0.000 description 1
- 102000012010 Sialomucins Human genes 0.000 description 1
- 108010061228 Sialomucins Proteins 0.000 description 1
- 208000005718 Stomach Neoplasms Diseases 0.000 description 1
- 101710120037 Toxin CcdB Proteins 0.000 description 1
- 102000002070 Transferrins Human genes 0.000 description 1
- 108010015865 Transferrins Proteins 0.000 description 1
- 230000005856 abnormality Effects 0.000 description 1
- 239000008351 acetate buffer Substances 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 230000000118 anti-neoplastic effect Effects 0.000 description 1
- 238000004166 bioassay Methods 0.000 description 1
- 230000003570 biosynthesizing effect Effects 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 239000003114 blood coagulation factor Substances 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 210000001124 body fluid Anatomy 0.000 description 1
- 239000010839 body fluid Substances 0.000 description 1
- 102000023852 carbohydrate binding proteins Human genes 0.000 description 1
- 230000005859 cell recognition Effects 0.000 description 1
- 230000000295 complement effect Effects 0.000 description 1
- 230000004154 complement system Effects 0.000 description 1
- 239000013078 crystal Substances 0.000 description 1
- 238000005520 cutting process Methods 0.000 description 1
- 230000001461 cytolytic effect Effects 0.000 description 1
- 210000000805 cytoplasm Anatomy 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 239000003989 dielectric material Substances 0.000 description 1
- 150000002016 disaccharides Chemical class 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 230000004720 fertilization Effects 0.000 description 1
- 210000004517 glycocalyx Anatomy 0.000 description 1
- 229940096919 glycogen Drugs 0.000 description 1
- 125000003147 glycosyl group Chemical group 0.000 description 1
- 230000013595 glycosylation Effects 0.000 description 1
- 238000006206 glycosylation reaction Methods 0.000 description 1
- 238000009396 hybridization Methods 0.000 description 1
- 239000001257 hydrogen Substances 0.000 description 1
- 210000000987 immune system Anatomy 0.000 description 1
- 230000006698 induction Effects 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 238000007689 inspection Methods 0.000 description 1
- 201000002313 intestinal cancer Diseases 0.000 description 1
- 230000009545 invasion Effects 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 208000017169 kidney disease Diseases 0.000 description 1
- 108010034897 lentil lectin Proteins 0.000 description 1
- 210000000265 leukocyte Anatomy 0.000 description 1
- 238000005461 lubrication Methods 0.000 description 1
- 201000005202 lung cancer Diseases 0.000 description 1
- 208000020816 lung neoplasm Diseases 0.000 description 1
- 210000004698 lymphocyte Anatomy 0.000 description 1
- 208000015486 malignant pancreatic neoplasm Diseases 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 230000013011 mating Effects 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 230000009401 metastasis Effects 0.000 description 1
- 238000002493 microarray Methods 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 239000000178 monomer Substances 0.000 description 1
- 201000011216 nasopharynx carcinoma Diseases 0.000 description 1
- 210000000653 nervous system Anatomy 0.000 description 1
- 229920001542 oligosaccharide Polymers 0.000 description 1
- 230000001717 pathogenic effect Effects 0.000 description 1
- 230000009054 pathological process Effects 0.000 description 1
- 230000035479 physiological effects, processes and functions Effects 0.000 description 1
- 230000035755 proliferation Effects 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- 230000022558 protein metabolic process Effects 0.000 description 1
- 230000035484 reaction time Effects 0.000 description 1
- 230000008929 regeneration Effects 0.000 description 1
- 238000011069 regeneration method Methods 0.000 description 1
- 108010038196 saccharide-binding proteins Proteins 0.000 description 1
- 210000003296 saliva Anatomy 0.000 description 1
- 238000007789 sealing Methods 0.000 description 1
- 230000035945 sensitivity Effects 0.000 description 1
- SQVRNKJHWKZAKO-OQPLDHBCSA-N sialic acid Chemical compound CC(=O)N[C@@H]1[C@@H](O)C[C@@](O)(C(O)=O)OC1[C@H](O)[C@H](O)CO SQVRNKJHWKZAKO-OQPLDHBCSA-N 0.000 description 1
- 229910052709 silver Inorganic materials 0.000 description 1
- 239000004332 silver Substances 0.000 description 1
- RPENMORRBUTCPR-UHFFFAOYSA-M sodium;1-hydroxy-2,5-dioxopyrrolidine-3-sulfonate Chemical compound [Na+].ON1C(=O)CC(S([O-])(=O)=O)C1=O RPENMORRBUTCPR-UHFFFAOYSA-M 0.000 description 1
- 108010048090 soybean lectin Proteins 0.000 description 1
- 210000000952 spleen Anatomy 0.000 description 1
- 201000000498 stomach carcinoma Diseases 0.000 description 1
- 230000002792 vascular Effects 0.000 description 1
- 238000005303 weighing Methods 0.000 description 1
Landscapes
- Investigating Or Analysing Biological Materials (AREA)
Abstract
Description
Claims (7)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2009103048853A CN101968440B (zh) | 2009-07-27 | 2009-07-27 | 一种利用表面等离子谐振技术检测特定糖链蛋白、抗体或抗原的生物芯片 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2009103048853A CN101968440B (zh) | 2009-07-27 | 2009-07-27 | 一种利用表面等离子谐振技术检测特定糖链蛋白、抗体或抗原的生物芯片 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN101968440A CN101968440A (zh) | 2011-02-09 |
CN101968440B true CN101968440B (zh) | 2011-11-09 |
Family
ID=43547625
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN2009103048853A Active CN101968440B (zh) | 2009-07-27 | 2009-07-27 | 一种利用表面等离子谐振技术检测特定糖链蛋白、抗体或抗原的生物芯片 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN101968440B (zh) |
Families Citing this family (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102507920A (zh) * | 2011-09-30 | 2012-06-20 | 西安交通大学 | 一种凝集素芯片及其应用 |
CN103344617B (zh) * | 2013-06-17 | 2015-05-06 | 重庆大学 | 光激活单分子荧光生物化学反应动力学显微镜及试验方法 |
ES2883628T3 (es) * | 2014-11-17 | 2021-12-09 | Univ Queensland | Biomarcadores de glucoproteínas para adenocarcinoma de esófago y esófago de Barrett y usos de los mismos |
CN105628934B (zh) * | 2016-02-05 | 2017-07-28 | 西北大学 | 特定凝集素组合在制备用以鉴别肺癌类型及分期的测试载体方面的用途 |
CN105785043B (zh) * | 2016-04-06 | 2018-02-02 | 上海良润生物医药科技有限公司 | 用于定量检测afp‑l3%的试剂盒 |
CN106596926B (zh) * | 2016-12-26 | 2018-04-10 | 上海微谱化工技术服务有限公司 | 一种氨基糖苷类抗生素的检测方法 |
CN109239182B (zh) * | 2018-09-04 | 2021-02-09 | 南京林业大学 | 一种用纤维素酶原位修饰金芯片的方法 |
CN110045125B (zh) * | 2019-04-03 | 2022-08-09 | 中国医学科学院北京协和医院 | 一种用于诊断腹膜后纤维化的生物标志物及其用途 |
CN114200137B (zh) * | 2020-09-16 | 2023-09-01 | 四川大学 | 一种以商品化磁珠为内标的比率免疫分析方法 |
CN114217062B (zh) * | 2020-09-18 | 2023-05-12 | 四川大学 | 一种基于单颗粒电感耦合等离子体质谱的多组分均相免疫分析方法 |
CN114032282A (zh) * | 2021-09-15 | 2022-02-11 | 陈翠英 | 一种前列腺癌检测试剂及其在前列腺癌检测中的应用 |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101144809A (zh) * | 2007-10-17 | 2008-03-19 | 中国科学院光电技术研究所 | 一种高灵敏度的纳米生物传感器制作方法 |
CN101303354A (zh) * | 2006-12-08 | 2008-11-12 | 中国科学院上海微系统与信息技术研究所 | 表面等离子体共振的生物传感器的生物芯片、制备及应用 |
-
2009
- 2009-07-27 CN CN2009103048853A patent/CN101968440B/zh active Active
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101303354A (zh) * | 2006-12-08 | 2008-11-12 | 中国科学院上海微系统与信息技术研究所 | 表面等离子体共振的生物传感器的生物芯片、制备及应用 |
CN101144809A (zh) * | 2007-10-17 | 2008-03-19 | 中国科学院光电技术研究所 | 一种高灵敏度的纳米生物传感器制作方法 |
Non-Patent Citations (4)
Title |
---|
JP特开2007-40974A 2007.02.15 |
张惠菊等.常见生物传感芯片及其应用进展.《生物技术通讯》.2008,第19卷(第6期), * |
张春秀等.制备蛋白质芯片的玻璃表面修饰方法比较.《中华检验医学杂志》.2003,第26卷(第4期), * |
李莹等.基于表面等离子体共振的土霉素残留检测.《应用激光》.2008,第28卷(第5期), * |
Also Published As
Publication number | Publication date |
---|---|
CN101968440A (zh) | 2011-02-09 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN101968440B (zh) | 一种利用表面等离子谐振技术检测特定糖链蛋白、抗体或抗原的生物芯片 | |
Unverzagt et al. | Structure− Activity Profiles of Complex Biantennary Glycans with Core Fucosylation and With/without Additional α2, 3/α2, 6 Sialylation: Synthesis of Neoglycoproteins and Their Properties in Lectin Assays, Cell Binding, and Organ Uptake | |
van der Merwe et al. | Analysis of cell-adhesion molecule interactions using surface plasmon resonance | |
Wang et al. | Prostate specific antigen biosensor based on long range surface plasmon-enhanced fluorescence spectroscopy and dextran hydrogel binding matrix | |
CN104379724B (zh) | 用于分析物的检测和测量的方法和装置 | |
Liang et al. | Iron oxide/gold core/shell nanoparticles for ultrasensitive detection of carbohydrate− protein interactions | |
Zhu et al. | Hydrophobic plasmonic nanoacorn array for a label-free and uniform SERS-based biomolecular assay | |
Mercey et al. | Polypyrrole oligosaccharide array and surface plasmon resonance imaging for the measurement of glycosaminoglycan binding interactions | |
Li et al. | Label-free sandwich imaging ellipsometry immunosensor for serological detection of procalcitonin | |
EP3159694B1 (en) | Sandwich assay using labeled lectin and kit therefor | |
Neng et al. | Detection of multiple pathogens in serum using silica-encapsulated nanotags in a surface-enhanced Raman scattering-based immunoassay | |
CN101975765B (zh) | 一种表面等离子体子共振传感元件及其制作方法 | |
Finetti et al. | Click chemistry immobilization of antibodies on polymer coated gold nanoparticles | |
Adak et al. | Fabrication of antibody microarrays by light-induced covalent and oriented immobilization | |
JPH04501606A (ja) | センサーユニット及びバイオセンサーシステムにおけるその使用 | |
CN102105798A (zh) | 实时连续检测装置 | |
EP2738556B1 (en) | Method for measuring amount of analyte and device for spfs | |
JP2013076666A (ja) | 表面プラズモン励起増強蛍光分光法を用いた前立腺特異抗原の定量方法 | |
JP4982793B2 (ja) | 生細胞表層分子解析方法及び部材 | |
EP2930514B1 (en) | Method for suppressing nonspecific signals from contaminants in an immunoassay using surface plasmon-field enhanced fluorescence spectroscopy (spfs) | |
Jiang et al. | Rapid enrichment and detection of extracellular vesicles enabled by CuS-enclosed microgels | |
Dou et al. | Voltammetric immunoassay for the detection of protein biomarkers | |
JPWO2009057755A1 (ja) | 糖鎖アレイ基板とそれを用いた糖鎖結合分子検出法 | |
Sizova et al. | The elaboration of effective coatings for photonic crystal chips in optical biosensors | |
CN102043046B (zh) | 一种检测糖链异常IgA肾病的蛋白芯片 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
ASS | Succession or assignment of patent right |
Owner name: XIONG HUI Free format text: FORMER OWNER: SHANGHAI HUIPU BIOPHARMACEUTICAL TECHNOLOGY CO., LTD. Effective date: 20110721 |
|
C41 | Transfer of patent application or patent right or utility model | ||
COR | Change of bibliographic data |
Free format text: CORRECT: ADDRESS; FROM: 201400 ROOM 3051, NO. 5885, JINHAI HIGHWAY, FENGXIAN DISTRICT, SHANGHAI TO: 201101 ROOM 1102, NO. 99, LANE 88, BAOMING ROAD, MINHANG DISTRICT, SHANGHAI |
|
TA01 | Transfer of patent application right |
Effective date of registration: 20110721 Address after: 201101, room 99, No. 88, Lane 1102, Bao Ming Road, Shanghai, Minhang District Applicant after: Xiong Hui Address before: 201400, room 5885, Jinhai Road, Fengxian District, Shanghai, 3051 Applicant before: Shanghai Huipu Biomedical Technology Co., Ltd. |
|
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
ASS | Succession or assignment of patent right |
Owner name: YANG YU Free format text: FORMER OWNER: XIONG HUI Effective date: 20120203 |
|
C41 | Transfer of patent application or patent right or utility model | ||
COR | Change of bibliographic data |
Free format text: CORRECT: ADDRESS; FROM: 201101 MINHANG, SHANGHAI TO: 200030 XUHUI, SHANGHAI |
|
TR01 | Transfer of patent right |
Effective date of registration: 20120203 Address after: 200030 room 520, No. 1004, Xuhui District, Shanghai, Yishan Road Patentee after: Yang Yu Address before: 201101, room 99, No. 88, Lane 1102, Bao Ming Road, Shanghai, Minhang District Patentee before: Xiong Hui |
|
ASS | Succession or assignment of patent right |
Owner name: SHANGHAI YUANQI BIOPHARMACEUTICAL TECHNOLOGY CO., Effective date: 20120502 |
|
C41 | Transfer of patent application or patent right or utility model | ||
TR01 | Transfer of patent right |
Effective date of registration: 20120502 Address after: 200030 room 520, No. 1004, Xuhui District, Shanghai, Yishan Road Co-patentee after: Shanghai Yuanqi Biological Medical Technology Co., Ltd. Patentee after: Yang Yu Address before: 200030 room 520, No. 1004, Xuhui District, Shanghai, Yishan Road Patentee before: Yang Yu |
|
C41 | Transfer of patent application or patent right or utility model | ||
TR01 | Transfer of patent right |
Effective date of registration: 20160810 Address after: 201403 Building 5, building 2066, 3 hope road, Shanghai, Fengxian District Patentee after: Shanghai Rui Rui Biological Technology Co., Ltd. Address before: 200030 room 520, No. 1004, Xuhui District, Shanghai, Yishan Road Patentee before: Yang Yu Patentee before: Shanghai Yuanqi Biological Medical Technology Co., Ltd. |
|
CP01 | Change in the name or title of a patent holder | ||
CP01 | Change in the name or title of a patent holder |
Address after: 201403 3rd floor, building 5, No. 2066, Wangyuan Road, Fengxian District, Shanghai Patentee after: Shanghai Ruian Gene Technology Co.,Ltd. Address before: 201403 3rd floor, building 5, No. 2066, Wangyuan Road, Fengxian District, Shanghai Patentee before: SHANGHAI RUIANG BIOTECHNOLOGY CO.,LTD. |
|
TR01 | Transfer of patent right |
Effective date of registration: 20220309 Address after: 201403 building 3, No. 6055, Jinhai highway, Fengxian District, Shanghai Patentee after: Shanghai Ruian Gene Technology Co.,Ltd. Patentee after: Changchun Jite Biotechnology Co., Ltd Address before: 201403 3rd floor, building 5, No. 2066, Wangyuan Road, Fengxian District, Shanghai Patentee before: Shanghai Ruian Gene Technology Co.,Ltd. |
|
TR01 | Transfer of patent right |